Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid Free Immunosuppression in Liver Transplantation
NCT00296244Phase 4Completed
- Sponsor
- Thomas Jefferson University
- Start
- Feb 2006
- Primary completion
- May 2008
- Modality
- Monoclonal Antibodies, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of basiliximab, tacrolimus + Wuzhi capsule, mycophenolic acid in liver transplantation, sponsored by Thomas Jefferson University. Started Feb 2006; status: completed.
02
Drugs
basiliximabtacrolimus + Wuzhi capsulemycophenolic acid
03
Conditions
liver transplantation
Beyond the preview
Go deeper on NCT00296244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00296244.